Bayer posts unexpected 1.9% gain in Q2 adjusted EBITDA
04/08/2026 06:40
Bayer posts unexpected 1.9% gain in Q2 adjusted EBITDA FRANKFURT, Aug 4 (Reuters) - Bayer BAYGn.DE on Tuesday reported an unexpected gain of 1.9% in quarterly operating profit on strong sales of agriculture products as well as of its pharmaceuticals Nubeqa and Kerendia.
Second-quarter earnings before interest, tax, depreciation and amortisation (EBITDA), adjusted for one-offs, came in at €2.14 billion ($2.46 billion), above market expectations of €1.94 billion in an analyst consensus posted on the group's website.
($1 = 0.8690 euros)
(Reporting by Ludwig Burger, Editing by Miranda Murray)
Recent news on Bayer AG
See all newsBrief: Bayer Says Finerenone Slowed Kidney Decline In CKD
Insight: How cheap Chinese antibiotics threaten Europe's last major penicillin plant
Deutsche Bank AG FF - Post Stabilisation Notice -Bayer EUR 30NC6 & 30NC9
Brief: Bayer To Present New Finerenone Data Across Chronic Kidney Disease With And Without Diabetes At Asn Kidney Week 2026
Brief: FDA Approves Once-Weekly Generic Hormone Therapy Patch For Women